Hyperuricemia Beyond Gout: The Unknown Culprit in Rheumatic and Musculoskeletal Diseases
Gout, Urate, and Crystal Deposition Disease · 23.04.2026 · 4 (2) · 9
DOI: 10.3390/gucdd4020009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gout, Urate, and Crystal Deposition Disease, online erschienen am 23.04.2026. Verfasst von Viola Klück und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hyperuricemia influences several aspects of the immune system. It enhances cytokine production by monocytes and activates neutrophils and natural killer cells. Within the adaptive immune system, hyperuricemia enhances antigen presentation, skews T helper cell differentiation toward the Th17 lineage and may also activate B cells. Beyond its established role in the pathogenesis of gout, hyperuricemia may therefore contribute to other rheumatic diseases. In this review, we summarize current evidence on the role of hyperuricemia in osteoarthritis, psoriatic arthritis, axial spondylarthritis, rheumatoid arthritis, systemic sclerosis, primary Sjögren’s disease and systemic lupus erythematosus. Available data do not support a causal role for hyperuricemia in the disease onset of osteoarthritis or rheumatoid arthritis. In contrast, hyperuricemia is associated with the development of psoriatic arthritis and may be linked to a more severe disease course. Small, predominantly cross-sectional studies further suggest a potentially adverse role of hyperuricemia in systemic sclerosis, Sjögren’s disease, and systemic lupus erythematosus. Across several rheumatic diseases, hyperuricemia is associated with cardiovascular disease, renal dysfunction and interstitial lung disease. However, both mechanistic and causal evidence remain limited, underscoring the need for more studies.
Zitieren
APA
Klück, V., Ponsteen, N., Leuven, S. I. V., & Joosten, L. A. B. (2026). Hyperuricemia Beyond Gout: The Unknown Culprit in Rheumatic and Musculoskeletal Diseases. Gout, Urate, and Crystal Deposition Disease, 4(2), 9. https://doi.org/10.3390/gucdd4020009
Vancouver
Klück V, Ponsteen N, Leuven SIV, Joosten LAB. Hyperuricemia Beyond Gout: The Unknown Culprit in Rheumatic and Musculoskeletal Diseases. Gout, Urate, and Crystal Deposition Disease. 2026;4(2):9. doi:10.3390/gucdd4020009
BibTeX
@article{Klck2026,
author = {Klück, Viola and Ponsteen, Nienke and Leuven, Sander I. van and Joosten, Leo A. B.},
title = {Hyperuricemia Beyond Gout: The Unknown Culprit in Rheumatic and Musculoskeletal Diseases},
journal = {Gout, Urate, and Crystal Deposition Disease},
year = {2026},
volume = {4},
number = {2},
pages = {9},
doi = {10.3390/gucdd4020009}
}
EUVIMED